Pharmacologic treatments for covid-19 patients

Peginterferon Lambda-1 vs Placebo


Outpatients

Forest plots
(last update: 2021-05-28)

Summary of findings
(last update: 2022-03-31)

To access all information :

You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.

Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=160

Back to your research

Trial Funding Comparisons Design Participants Sample size Overall risk
of bias
Highest assessment
Full description
Treatment 1 Treatment 2
NCT04354259
ILIAD
Feld JJ, Lancet Respir Med, 2021
Full text
Commentary
Commentary
Mixed

Peginterferon Lambda-1

Placebo

RCT Outpatients with confirmed COVID-19 (mild) tested at 6 centers in Canada N=60
Some concerns
Details

Full description

NCT04331899
Jagannathan P, Nature, 2021
Full text
Commentary
Commentary
Mixed

Peginterferon Lambda-1a

Placebo

RCT Outpatients with confirmed COVID-19 (asymptomatic/symptomatic, mild) treated at a single center in the USA N=120
Some concerns
Details

Full description